Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients
Imiquimod 5% cream in the treatment of external genital or perianal warts in HIV+ patients
Warts
DRUG: Imiquimod 5% cream
The percentage of subjects with total clearance of initially treated external genital or perianal warts., week 16
Total clearance, week 16|Percentage of subjects with a partial reduction of initial wart area;, week 16|Time to achieve reduction in wart area;, week 16|Reduction in wart number, week 16|Appearance of new warts, week 16|Recurrence rate, week 16|HPV DNA, week 16|CD4+ lymphocyte and HIV RNA levels, week 16
To evaluate the percentage of HIV+ subjects successfully treated with HAART, with total clearance (100%) of baseline external genital or perianal warts within 16 weeks of treatment with imiquimod 5% cream.